Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-26 @ 12:16 PM
Ignite Modification Date: 2025-12-26 @ 12:16 PM
NCT ID: NCT02585700
Description: None
Frequency Threshold: 1
Time Frame: 90 days
Study: NCT02585700
Study Brief: A Study of a Seasonal Trivalent Split, Inactivated Influenza Vaccine
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Vaccine Group 0.5 mL of influenza vaccine, split, inactivated with 15 mcg of HA of each of 3 strains: * NYMC BX-51B reassortant of B/Massachusetts/2/2012 * X-181 reassortant of H1/A/California/7/2009 * X-223A reassortant of H3/A/Texas/50/2012. 0 None 0 30 2 30 View
Placebo Group 0.5 mL of phosphate buffered saline 0 None 0 30 4 30 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Respiratory Tract Infection SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA (18.1) View
Diarrhea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (18.1) View
Alanine Aminotransferase Increased SYSTEMATIC_ASSESSMENT Investigations MedDRA (18.1) View
Back Pain SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA (18.1) View
Cough SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA (18.1) View